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ABSTRACT
Hepadnaviruses are DNA viruses that replicate by
protein-primed reverse transcription, employing a
specialized reverse transcriptase (RT), P protein.
DNA synthesis from the pregenomic RNA is initiated
by binding of P to the e signal. Using e as template
and a Tyr-residue for initiation, the RT synthesizes a
DNA oligo (priming) as primer for full-length DNA.
Priming strictly requires prior RT activation by
chaperones. Active P–e complexes have been
reconstituted in vitro, but whether in addition to
the heat-shock protein 70 (Hsp70) system the Hsp90
system is essential has been controversial. Here we
quantitatively compared Hsp70 versus Hsp70 plus
Hsp90 RT activation, and corroborated that the
Hsp70 system alone is sufficient; however, Hsp90
as well the Hsp70 nucleotide exchange factor Bag-1
markedly stimulated activation by increasing the
steady-state concentration of the activated meta-
stable RT form P
 , though by different mechanisms.
Hsp90 inhibition in intact cells by geldanamycin
analogs blocked hepadnavirus replication, however
not completely and only at severely cytotoxic
inhibitor concentrations. While compatible with a
basal level of Hsp90 independent in vivo replication,
unambiguous statements are precluded by
the simultaneous massive upregulation of Hsp70
and Hsp90.
INTRODUCTION
Hepatitis B virus (HBV), the causative agent of B-type
hepatitis in humans, is the prototype of the hepadna-
viruses, small DNA-containing viruses that replicate
through reverse transcription (1,2); due to various
experimental restrictions with HBV, duck hepatitis B
virus (DHBV) provides an important model system (3).
In all hepadnaviruses, a more than genome length
transcript, the pregenomic RNA (pgRNA), acts as
mRNA for the capsid protein and the viral reverse
transcriptase (RT), termed P protein, and the same
RNA is packaged into viral capsids and there it is reverse
transcribed into progeny DNA genomes.
Hepadnavirus replication diﬀers distinctively from that
of retroviruses, reﬂected by the presence in P proteins of
an extra terminal protein (TP) domain. Both pgRNA
encapsidation and initiation of DNA synthesis are
triggered by the binding of P to a 50-proximal RNA
stem-loop, e, on the pgRNA. Once the RT is bound to e,
a Tyr-residue in the TP domain, rather than a tRNA,
serves for the protein-primed synthesis of a 3 or 4nt,
e-encoded, and covalently TP-linked DNA oligonu-
cleotide (‘priming reaction’; Figure 1A). Subsequently,
the complex translocates to a 30 proximal RNA element,
DR1
 , and the oligo is extended into complete minus-
strand DNA which remains covalently bound to the RT;
plus-strand DNA synthesis eventually yields the relaxed
circular (RC) DNA present in virions released from
the cell.
Mechanistic studies have long been hampered by the
lack of soluble recombinant P protein. Initial cell-free
studies (4) performed in rabbit reticulocyte lysate (RL)
showed that in vitro translated RT from DHBV though
not from HBV (5) was capable of performing the
authentic, e-dependent priming reaction when provided
with DHBV e (De) RNA and dNTPs (Figure 1A);
this system also revealed that formation of an active
replication initiation complex is a multi-step process
requiring speciﬁc interactions between P protein and De
(6–10) that induce functionally crucial structural
rearrangements in both the protein and the RNA (7,11).
Most notably here, complex formation was found to
be strictly dependent on cellular chaperones (12,13)
which are abundantly present in RL; this very fact,
however, also precluded clear-cut distinctions as to which
chaperones are absolutely required for P activation,
and which are not.
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(Hsps), are essential in all cells to prevent accumulation
of misfolded proteins. The major eukaryotic cytosolic
chaperone systems, besides the 60kDa Hsp60 chaperonins
(GroEL in bacteria), are Hsp70 including its constitutive
form Hsc70 and Hsp90; in addition to ATP, their
chaperoning activities depend on, and are modulated by,
various co-chaperones (14–16). Hsp70 (DnaK in bacteria),
in concert with Hsp40 (DnaJ in bacteria) and/or other
J domain proteins (16), has usually more generalized
roles such as folding of non-native, e.g. nascent or
misfolded, proteins whereas few examples are known
for a direct regulation of the activity of native substrates;
in bacteria, these include the transcription factor s32
(17,18), and proteins involved in phage and plasmid
replication (19); in eukaryotes, a classic example is
clathrin-coated vesicle uncoating via Hsc70 and the large
J domain protein auxilin (20). Hsp90, not required for
the biogenesis of most proteins (21), acts as a more
specialized chaperone in activating various near-native
client proteins (22,23), including many important regula-
tory molecules such as steroid hormone receptors and
kinases (24,25). A comprehensive list of interaction
partners may be found at http://www.picard.ch. Usually
Hsp90 action requires cooperation with the Hsp70 system
(26,27), mediated by the Hsp70-Hsp90 organizing protein
(Hop) (25).
Based on data from the RL system and on the
interference with viral replication in DHBV transfected
cells by the Hsp90 inhibitor geldanamycin (GA)
chaperone activation of the hepadnaviral RT was
suggested to occur similar to that of steroid hormone
receptors (12,13); there, ligand-binding competence is
gained by sequential reactions with Hsp70 acting early,
and Hsp90 late in the cycle (28,29) with additional factors
being involved such as p23 and immunophilins (30).
Importantly, Hsp90 appears absolutely required for
receptor maturation.
Recent successes in producing recombinant DHBV
P protein from Escherichia coli as fusions with solubility
enhancing domains such as NusA or GrpE (8,31), or GST
(32,33) enabled the in vitro reconstitution of priming-
active RT complexes entirely from puriﬁed components,
allowing to dissect the roles of individual chaperones.
For the GST-fused P protein, a strict dependence on both
the Hsp70 and Hsp90 systems was reported (33) except
when the entire RNase H domain was removed (34);
our own data (31), mainly using the NusA-fused P protein
(NusDP), indicated instead that Hsc70 and Hsp40
plus ATP are necessary and suﬃcient to generate the
activated, metastable state P
  (Figure 1B).
To resolve these seemingly discordant results and given
the limited knowledge on the molecular mechanisms
of client protein activation by chaperones, in particular
by Hsp90 (23), we compared in detail how the Hsp70 and
the Hsp90 systems, alone or in combination, inﬂuence
in vitro hepadnavirus RT activation (Figure 1B).
In addition, we speciﬁcally modulated the Hsp70 and
Hsp90 chaperoning activities. For Hsp90, we used
mutants defective for ATPase activity or interaction with
Hop. For Hsc70, we aﬀected the ADP–ATP exchange
rate by the Hsp70 nucleotide exchange factor Bag-1 (35).
Bag-1 belongs to a family of proteins (36) which all
contain at least one copy of a conserved, roughly
50-amino-acid-long Bag-domain that mediates their inter-
action with Hsp70 (36–38). A hallmark of Hsp70 activity
is the cyclic binding and release of substrates, driven by
ATP hydrolysis and ADP–ATP exchange (16). Bag-1
accelerates this cycle by increasing the ADP–ATP
exchange rate (39) which, depending on the Bag-1 isoform
(40) and the Bag-1 to Hsp70 ratio (39), may increase
or decrease overall chaperone activity (35,39–42)
Corroborating our previous conclusion we found that
the Hsp70 system plus ATP was suﬃcient to activate
P protein, yet activation was signiﬁcantly stimulated both
by Bag-1 and by Hsp90 plus Hop, though by diﬀerent
mechanisms. Hence the hepadnaviral RT represents an
unusual chaperone client that can be fully matured,
in vitro, into an active state by the Hsp70 system yet
the level of activation remains tunable by the Hsp90
system. We also re-examined the eﬀects of Hsp90
inhibition on virus replication in intact cells. Only under
special conditions did we observe a signiﬁcant though
incomplete reduction of viral DNA synthesis. Notably,
this inhibition required inhibitor concentrations that
exerted substantial cytotoxicity and induced a strong
heat-shock response, including the upregulation of
Hsp70 and Hsp90 itself. Hence whether or not Hsp90 is
essential for hepadnavirus replication in vivo remains to
be determined.
Figure 1. (A) Current model of replication initiation by hepadnaviral
P proteins. DHBV P protein, with its terminal protein (TP) and reverse
transcriptase/RNase H (RT/RH) domains linked through a dispensable
spacer, is unable to bind De RNA without prior chaperone-mediated
conversion into a metastable, active conformation (P
 ). In vitro
activation strictly requires Hsc70, Hsp40 and ATP. The necessity
for Hop and Hsp90 has been controversial (31,33). De RNA binding
is accompanied by structural changes in the RNA and the RT, enabling
the synthesis of a short DNA oligonucleotide templated by a bulged
region within De (priming); its 5’-terminal nucleotide is covalently
linked to a Tyr residue in the TP domain. (B) Diﬀerent states
of hepadnaviral RT activation. P represents the non-activated state.
Chaperones and energy are required to produce, and maintain,
activated metastable P
  which is able to bind De RNA. The steady-
state P
  concentration depends on the rates of P
  production and
decay. Upon energy depletion P
  decays within minutes whereas P–De
RNA complexes are stable over hours (31).
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Recombinant DHBVRT
DHBV P proteins with an internal deletion of the
dispensable spacer region and an additional deletion
of 25 amino acids from the C terminus were expressed
in E. coli as fusion proteins with GrpE (termed GrpDP)
and NusA (termed NusDP) and puriﬁed as previously
described (31). Notably, this procedure removes most of
the bacterial chaperones DnaK and GroEL, which have
been reported to be present in up to stoichiometric
amounts in recombinant GST-P preparations (32). From
sodium dodecyl sulfate–polyacrylamide gel electrophor-
esis (SDS–PAGE) analysis and scanning the Coomassie
Blue stained bands, we estimate that the bacterial
chaperones accounted for between 10, and 20%, of the
full-length RT protein in both the GrpDP and NusDP
preparations used (Supplementary Figure S1).
Chaperones
Genes for rat Hsc70 (43), human Hsp40 (Hdj1) (44),
human Hop (45), murine Bag-1S (42) and the mutant
Bag-1S-R182A (Bag-1S Arg to Ala substitution at amino
acid position 182) were cloned into a modiﬁed pET30a
vector (Novagen) downstream of a hexa-histidine tag
and a TEV protease cleavage site (cloning details are
available upon request). The proteins were expressed in
E. coli BL21 Star cells (Invitrogen) supplemented with the
Codon Plus RIL plasmid (Stratagene) and puriﬁed by
immobilized metal aﬃnity chromatography (IMAC)
using HisTrap columns and FPLC equipment (GE
Healthcare). Subsequently the His-tags were cleaved oﬀ
with tobacco etch virus (TEV) protease and removed by
immobilization to IMAC resin. The puriﬁed proteins were
dialyzed against storage buﬀer [20mM Tris pH 7.5,
150mM NaCl, 10% (v/v) glycerol, 1mM DTT, 0.1%
(v/v) complete EDTA-free protease inhibitor cocktail
(Roche)] and stored at –808C. The Bag-1C expression
construct was obtained by insertion of a PCR-ampliﬁed
DNA fragment encoding amino acids 96–219 of the
murine Bag-1S protein (corresponding to amino acids
232–355 of murine Bag-1L, GenBank Accession Number
AF022223) into the vector pET30a. The resulting plasmid
encodes a non-cleavable hexa-histidine tag at the
carboxy-terminus of Bag-1C. Expression and puriﬁcation
were performed as described above. Human Hsp90b
was puriﬁed to homogeneity from baculovirus-infected
insect cells essentially as previously described (46). Native
dimeric state and ATPase activity were conﬁrmed by gel
ﬁltration and ATPase assay, respectively. Wild-type yeast
Hsp90 (Hsp82) and its deletion variants yHsp90
MEEVD (lacking 5C terminal amino acids) and yHsp
9016 [lacking 16N terminal amino acids (47)] were
cloned into the vector pET28b (Novagen) downstream of
a hexa-histidine tag (48). Proteins were expressed in E. coli
BL21 Star cells and puriﬁed by IMAC, anion exchange
chromatography and gel ﬁltration essentially as previously
described (48), and stored at –808C. An SDS–PAGE
analysis of all recombinant proteins used is shown in
Supplementary Figure S1.
Reconstitution of Pprotein–De RNA complexes
Standard reconstitution reactions contained 150nM
(150ng) GrpDP, 4.2mM( 3 mg) Hsc70, 5.3mM( 2 mg)
Hsp40, 0.6mM (0.5mg) Hsp90, 0.9mM (0.5mg) Hop,
2ml TKD buﬀer (100mM Tris–HCl, pH 7.5; 250mM
KCl; 10mM DTT), 1ml of an ATP regenerating system
(50mM ATP, 25mM MgCl2, 250mM creatine phosphate,
100U/ml phosphocreatine kinase), 10U of RNasin RNase
inhibitor (Promega), 1mM in vitro transcribed De RNA
(31) and H2O up to a ﬁnal volume of 10ml. In some
experiments, lower GrpDP concentrations were used as
indicated. Where appropriate, Bag-1S or mutant Bag1
proteins were included at the indicated concentrations.
To allow for P–De complex formation samples
were incubated at 308C for 3.5h (reconstitution reaction).
Prior analyses had shown that the Hsc70/Hsp40 only,
as well as the Hsp90/Hop, supplemented reactions
remained in a linear phase for at least 5h. Enzymatic
activities of reconstituted P–De complexes were subse-
quently examined by adjusting the reactions to [a
32P]-
dATP priming conditions as previously described (31,49).
Due to the distinct buﬀer conditions, including the
presence of 0.2% (v/v) NP-40 detergent, no further RT
activation by the chaperones occurs whereas already
formed P–De complexes remain largely stable (31).
The priming signal intensity is therefore an approximate
measure of the amount of P–De complexes formed during
the reconstitution reaction. Samples were separated
by SDS–PAGE and
32P-labeled RT proteins were detected
by autoradiography or phosphorimaging (BAS-1500,
Fuji) and quantiﬁed using MacBas software (Fuji).
Relative affinity ofin vitro activated RTfor De RNA
P–De complexes were reconstituted at standard conditions
from 150nM GrpDP and increasing amounts of
De RNA (ranging from 2.5nM to 2mM) in the presence
of standard concentrations (see before) of either Hsc70
and Hsp40, or in the additional presence of Hsp90 and
Hop. Functional P–De complexes were detected by
32P-dATP priming assays. Priming signal intensities
(I[De]) for each De concentration [De] were quantiﬁed
by phosphorimaging. To determine the parameters
Kd (a nominal apparent dissociation constant) and Imax
(theoretical maximum priming intensity at saturating
concentration of De) for each of the two data sets
hyperbolic regression analyses according to following
equation were performed:
I½D"  ¼ Imax  ½ D" =ðKd þ½ D" Þ
Detection ofP–De complexes by RNA gel shiftassay
For direct detection of P–De complexes by RNA gel shift
assays (50), reconstitution reactions were assembled under
standard conditions using 150ng of NusDP protein,
except that TKD buﬀer was replaced by TMNK buﬀer
(100mM Tris–HCl, pH 7.5; 10mM MgCl2; 75mM NaCl;
100mM KCl, 20mM DTT) supplemented with EDTA-
free protease inhibitor cocktail, and the De RNA
was
32P labeled (31). Samples were analyzed by native
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polyacrylamide gels (acrylamide:bis-acrylamide ratio
80:1) containing 2.5% (v/v) glycerol. Signals were detected
by autoradiography.
Hsp90 inhibition byGA analogs 17-DMAG and17-AAG
17-(Dimethylaminoethylamino)-17-demethoxygeldanamy-
cin (17-DMAG) and 17-allylamino-17-demethoxygelda-
namycin (17-AAG) were obtained from Invivogen, and
1mM stock solutions in H2O (17-DMAG) and DMSO
(17-AAG) were prepared. The impact of the drugs on the
chicken hepatoma cell line LMH was assessed by
incubating cells, cultured as previously described (51),
in the presence of the indicated drug concentrations for 24
or 48h; for 17-AAG, DMSO at the concentration
corresponding to that at the highest drug dose was used
as negative control. For transfections with the DHBV
expression vector pCD16 (52) TransIT-LT1 (Mirus)
reagent was used as recommended by the manufacturer.
In brief, cells in 6-well plates were incubated at 50–60%
conﬂuency with the transfection reagent/DNA mixture for
14–16h; thereafter, medium was changed and the cells
were maintained for the indicated time periods. Drug was
added immediately after the transfection phase, or added
1 or 6h prior to transfection, and maintained at the same
concentration throughout the experiments. Cells were
harvested and cytoplasmic lysates were prepared as
described (51). Total protein concentration in the lysates
was determined using the bicinchoninic acid (BCA) assay
as recommended by the manufacturer (Pierce). Viral DNA
from cytoplasmic nucleocapsids was isolated and
detected by Southern blotting as described (53). Primary
antibodies for western blotting were T9026 (anti-tubulin;
Sigma); AC88 (anti-Hsp90a/b; Stressgen); and SPA-757
(anti-Hsc70/Hsp70; Stressgen). For detection, the blots
were incubated with appropriate peroxidase or alkaline
phosphatase conjugated secondary antibodies, followed
by ECL
+ (GE Healthcare) or CDP
  reagent (Roche),
respectively. Chemiluminescent signals were recorded on
X-ray ﬁlm or on a Fuji LAS 3000 instrument, and
quantiﬁed using AIDA software. In vitro inhibitory
activity of 17-DMAG was addressed by performing
P–De complex reconstitutions, as described above, in the
presence of the indicated concentrations of the drug and
subsequent priming assays.
RESULTS
Stimulatory but non-essential role of Hsp90 plus Hopin RT
activation invitro
Initiation of DNA synthesis by P protein requires ﬁrst that
the De template RNA be bound, for which chaperone
assistance is obligatory. Successful initiation results in the
covalent attachment of the De templated DNA oligo to
the RT. Hence, in the presence of a-
32P labeled dNTPs,
P protein in priming-competent complexes becomes
radioactively labeled and can sensitively and quantita-
tively be detected by autoradiography (‘priming assay’;
see Figure 1A). In our previous study, most experiments
had been performed with a NusA-fused DHBV P protein
(NusDP). Because the GrpE-fused protein (GrpDP)
appeared to have similar properties (31) yet a smaller
heterologous part (23kDa for GrpE versus 55kDa
for NusA), GrpDP was used in the current study.
In addition, instead of His-tagged Hsp40 and commercial
bovine Hsc70 we here employed E. coli-derived prepara-
tions of tag-free human Hsp40 (Hdj1) and rat Hsc70;
this excluded any contamination of the Hsc70/Hsp40
only reactions with eukaryotic Hsp90.
To establish that all these components were functional
GrpDP (150nM) was incubated under standard condi-
tions (see Materials and Methods section for details)
with various combinations of De RNA, Hsc70, Hsp40,
Hsp90 and Hop, always in the presence of an
ATP-regenerating system. Potential priming products
were analyzed by SDS–PAGE and autoradiography.
As shown in Figure 2A, GrpDP could be activated by
Hsc70 plus Hsp40 (lane 3) but not by either of the two
chaperones alone (lanes 1 and 2). Hsp90, in the absence of
Hsc70, or Hsp40, or De RNA (lanes 4, 5 and 6),
was unable to promote any P activity. However, when
all basic Hsp70 components and, in addition, Hop were
present, Hsp90 caused an  5-fold, Hop-dependent
increase in signal strength (lane 7).
Hence these data corroborated that for RT activation
Hsc70 and Hsp40 plus energy are suﬃcient and necessary,
whereas Hsp90 plus Hop have a stimulatory but non-
essential role. Because these results remained in contrast
to the strict requirement for Hsp90/Hop reported
by others (33), we suspected that the low amounts
of recombinant RT used there (10nM) could have
obscured detectable priming activity in the absence of
Hsp90/Hop. We therefore performed reconstitution
assays in which decreasing concentrations of GrpDP
(from 160 to 5nM) were incubated with ﬁxed amounts of
the various chaperones. Beforehand, we titrated the Hsp90
concentration required for maximal stimulation at 10nM
GrpDP concentration. Stimulation showed an initial
linear increase which leveled oﬀ at  0.6mM Hsp90
(Figure 2B); this Hsp90 concentration was used in the
subsequent experiments. Decreasing the amount of
GrpDP reduced, expectedly, the strength of the priming
signals (Figure 2C). Without Hsp90/Hop, signals became
barely detectable, except upon long-term exposure,
around 10nM P protein. Inclusion of Hsp90/Hop
increased the signals, in the range of 4- to 5-fold at the
higher, and up to  8-fold at the lowest P concentrations,
resulting in an easily detectable signal. Hence the
seemingly strict Hsp90/Hop dependence of P activation
may be due to quantitative rather than qualitative
diﬀerences between the assay systems used.
StimulatoryactivityofHsp90dependsonitsabilitytointeract
withHopbut can occurindependent from Hsp90 ATPase
activity
Complete passage through the Hsp90 chaperoning
cycle requires its intrinsic ATPase activity (23,54,55) but
Hsp90 can also display nucleotide-independent ‘passive’
chaperoning activity (56,57). To dissect whether Hsp90
ATPase activity is necessary for the stimulatory activity
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simultaneously block the Hsp70 system, which is itself
required for Hsp90 stimulation (Figure 2A). Therefore
we employed a variant Hsp90, yHsp9016, which is
essentially deﬁcient in ATP hydrolysis (47). Second,
the dependence on Hop of Hsp90 stimulation had
suggested that an interaction between the two proteins
was necessary. To address this point, we used the mutant
yHsp90MEEVD, which lacks the primary C terminal
Hop interaction motif (58). Both proteins were available
as the yeast Hsp90 homologs. We therefore ﬁrst estab-
lished that wild-type yeast Hsp90 can functionally
substitute for the human Hsp90 used in the previous
experiments; this was indeed the case, with comparable
(3.9-fold) stimulation of the Hsc70/Hsp40-mediated acti-
vation (Figure 3). Only a slight increase (1.3- to 1.4-fold)
was seen with yHsp90MEEVD but yHsp9016 stimu-
lated activation signiﬁcantly (2.9-fold), yet only in the
presence of Hop. These results were reproduced in three
independent experiments. These data suggest that Hsp90
stimulation of RT activation does not require ATP
hydrolysis, yet it is still dependent on Hop as an adaptor
to Hsc70/Hsp40.
The Hsc70 nucleotide exchange factorBag-1 stimulates
Hsc70/Hsp40-mediated RT activation
A typical feature of authentic chaperoning activity is the
transient, iterative and ATP-consuming interaction with
substrates. Stable substrate binding by Hsp70 requires
ATP hydrolysis; Hsp40 serves to stimulate the Hsc70
ATPase activity, leading to increased levels of Hsc70
ADP.
At the concentrations of Hsc70 and Hsp40 used here,
Hsp40 is not limiting (31). Initiation of a new chaperoning
cycle requires that the Hsc70-bound ADP (Hsc70
ADP)
can be exchanged for ATP; this naturally slow reaction
might therefore be rate limiting. To test this conjecture,
we exploited the nucleotide exchange factor Bag-1 and
supplemented the minimal reconstitution system consist-
ing of GrpDP, De RNA, Hsc70 and Hsp40 plus ATP,
with various concentrations of Bag-1, in the form of Bag-
1S (Figure 4A). Bag-1S signiﬁcantly stimulated Hsc70/
Hsp40-mediated P protein activation in a concentration-
dependent manner (Figure 4B). The activating eﬀect was
optimal at concentrations around 5mM, corresponding
to an equimolar ratio of Bag-1S to Hsc70. In this
range, we observed a reproducible 4- to 5-fold increase
in priming competent P–De complexes. Further rising the
Bag-1S concentration lowered the stimulatory activity.
Stimulation was not due to non-speciﬁc stabilization
Figure 2. Chaperone dependence of priming-active P–De complex
formation. (A) Stimulatory role of Hsp90. P protein–De complexes
were reconstituted from GrpDP (150nM) in the presence of the
indicated chaperones and subsequently subjected to priming assays.
Samples were separated by SDS–PAGE and the
32P-labeled P protein
was visualized by autoradiography. (B) Eﬀect of Hsp90 concentration
on complex reconstitution. P protein–De complexes were reconstituted
from GrpDP (10nM), and ﬁxed concentrations of Hsc70, Hsp40, Hop
and De RNA plus varying concentrations of Hsp90 as indicated. Active
complexes were detected by priming assays.
32P-labeled P protein was
visualized by phosphorimaging (inset), and the quantiﬁed values were
plotted against the Hsp90 concentration. (C) Eﬀect of P protein
concentration on complex reconstitution. P–De complexes were
reconstituted with increasing concentrations of GrpDP in the presence
of ﬁxed concentrations of Hsc70 and Hsp40 only (upper panel), or in
the additional presence of Hsp90 and Hop (lower panel). Complex
formation was analyzed by priming assays as in (A).
Figure 3. Eﬃcient Hsp90 stimulation requires Hop but not the
ATPase activity of Hsp90. P–De RNA complexes were reconstituted
from GrpDP and Hsc70/Hsp40 in the absence of Hsp90 and Hop, or in
the additional presence of Hop and wild-type yeast Hsp90 (lane wt),
or the yeast Hsp90 variants MEEVD or yHsp9016 (lanes 16).
The stimulatory activity of yHsp9016 was abolished when Hop
was omitted (lane 16–Hop). Complex formation was monitored
by priming assays as in Figure 2. Relative signal intensities are
given below each lane, with the signal from the unsupplemented
reaction set at 1.0.
6128 Nucleic Acids Research, 2007, Vol. 35, No. 18of the RT because bovine serum albumin had no
eﬀect (Figure 4B). These data indicate that in the minimal
Hsc70/Hsp40 reconstitution system the exchange
of ADP for ATP on Hsc70 is rate limiting for P
protein activation.
Since we are using GrpE–P protein fusion proteins,
it is important to note that although GrpE is a functional
E. coli homolog of Bag-1, it does not aﬀect the nucleotide
exchange rate of eukaryotic Hsc70 (35). This was
conﬁrmed in that activation of the NusDP fusion protein
was similarly stimulated by Bag-1S (data not shown).
Conversely, Bag-1 cannot stimulate bacterial Hsp70 (35).
These data also indicate that residual bacterial DnaK and
GroEL, amounting to at most 10–20% of the amount
of full-length RT protein present in the recombinant
preparations (see Materials and Methods section,
and Supplementary Figure S1), cannot account for the
observed RT activation. Furthermore, replacement
of eukaryotic Hsc70 and Hsp40 by bacterial DnaK and
DnaJ plus ATP under otherwise identical conditions
did not lead to any RT activation (data not shown).
Afunctional Bag domainis necessary andsufficient for
stimulation of Hsc70/Hsp40-mediated RT activation
In order to deﬁne the minimal domain of Bag-1S required
for stimulation of replication initiation complex forma-
tion, we used a deletion mutant, Bag-1C, that comprises
only the Bag domain. Speciﬁcally, it is the murine
homolog of a fragment of human Bag-1M (amino
acids 151–274) that has been shown to functionally
interact with Hsc70 via enhancing its nucleotide exchange
rate (39). Bag-1C stimulated the formation of priming-
competent initiation complexes to a similar extent
( 4-fold), and with similar concentration dependence, as
Bag-1S (Figure 4C). Stimulation was maximal at  5mM
Bag-1C and declined at higher concentrations, as with
Bag-1S; at the highest concentration tested (20mM)
Hsc70/Hsp40 activation was inhibited.
To formally prove that the stimulation was caused
by accelerated nucleotide exchange on Hsc70 we also
tested a point mutant of Bag-1S, Bag-1S-R182A, in which
the single Arg to Ala substitution in the Bag domain
renders the protein deﬁcient for promoting nucleotide
exchange (59). As shown in Figure 4C, Bag-1S-R182A
did neither stimulate nor inhibit P protein activation at
any concentration tested. Together, these data demon-
strated that the Bag domain is suﬃcient for enhancement
of Hsc70/Hsp40-mediated P protein activation, provided
its ability to accelerate nucleotide exchange on Hsp70 is
intact. Hence, most likely Bag-1 stimulates RT activation
by direct interaction of the Bag domain with the ATPase
domain of Hsc70.
CombinedBag-1S plus Hsp90/Hop stimulation of RT
activation
The above described data had shown that both Hsp90/
Hop and Bag-1S stimulated Hsc70/Hsp40-mediated RT
activation. We next analyzed which eﬀects a combination
of Bag-1S plus Hsp90/Hop had on the basal Hsc70/Hsp40
activation of P protein. Standard reconstitution
assays were performed with Hsc70, Hsp40, Hop and
Hsp90, plus increasing amounts of Bag-1S as described
earlier, and compared with reactions lacking Hsp90
and Hop (Figure 5); to ensure that, in the simultaneous
presence of Bag-1S stimulation, Hsp90 would not
become limiting these experiments were performed
at low GrpDP concentration (10nM). As before, the
Hsc70/Hsp40-only-mediated activation was maximally
stimulated, by 4- to 5-fold, at an optimal Bag-1S
concentration of around 5mM. The Hsp90/Hop supple-
mented reactions, starting oﬀ at  5-fold higher levels,
were similarly aﬀected by Bag-1S, with essentially the
same concentration dependence. In fact, up to the optimal
Bag-1S concentration, the two curves were almost super-
imposable, with a nearly constant diﬀerence in relative
Figure 4. Eﬀect of Bag-1 on GrpDP activation. (A) Schematic
representation of the examined Bag-1 variants. The Bag-domain and
the ubiquitin-like domain are shaded in dark and light gray,
respectively. Numbers refer to amino acid positions. The Arg to Ala
mutation at amino acid 182 in Bag-1S-R182A is indicated. (B) Bag-1S
enhances Hsc70/Hsp40-mediated P protein activation. P protein–De
complexes were reconstituted from GrpDP, Hsc70 and Hsp40 in the
presence of varying amounts of Bag-1S (open circles) or BSA
(ﬁlled triangles), and complex formation was monitored by priming
assays. Priming signals were quantiﬁed and plotted against the
concentration of the respective protein added, with the value obtained
without addition of Bag-1S and BSA set to 100%. The relative priming
activities are given as means   SD from between two and ﬁve
independent experiments, each determined in duplicate. (C) The Bag
domain is suﬃcient to stimulate P protein activation and acts
by aﬀecting nucleotide exchange on Hsc70. Standard Hsc70/Hsp40
reconstitution reactions were supplemented with the indicated
amounts of Bag-1C (open circles), or the non-functional mutant
Bag-1S-R182A (ﬁlled triangles). Relative priming activities were
determined as in (A).
Nucleic Acids Research, 2007, Vol. 35, No. 18 6129priming eﬃciencies. Hence the extent of Hsp90/Hop
stimulation was limited by the available levels of Hsc70/
Hsp40-pre-activated P protein. The mutant Hsp90 protein
defective for Hop interaction had essentially no eﬀect
(data not shown).
Hsp90/Hop affectthe quantity, notthequality, of Hsc70/
Hsp40-activated RT molecules
Because De must be bound to P to act as priming template
and because P–De complexes are relatively stable (31),
the priming signal intensities are generally proportional to
the amount of these complexes present in the reaction.
However, such proportionality is not necessarily direct.
For instance, Hsp90 acting on the Hsc70/Hsp40 pre-
activated P
  molecules might create a distinct activated
form, P
  , that has an increased aﬃnity for De RNA; or it
could enhance the ability of the RT to utilize the bound
RNA as template; in this scenario, the same amounts of
P–De complexes would lead to stronger priming signals.
To address the ﬁrst point, we compared the relative
aﬃnities for De RNA of Hsp70 system versus Hsp70 plus
Hsp90 system activated RT. Reconstitution reactions
containing ﬁxed concentrations of all protein components
were incubated with increasing amounts of De RNA, then
priming assays were performed (Figure 6A). The absolute
priming signal intensities were, expectedly, higher in
the Hsp90/Hop supplemented reactions, yet the De
concentration dependence was virtually unchanged, with
half-maximal signal intensities at  0.3mM RNA, close to
the value measured for in vitro translated P protein in RL
(60). Hence Hsp90/Hop did not increase the apparent
aﬃnity of P
  for its template RNA.
To address the second point, we used RNA gel shift
assays to directly monitor the relative amounts of P–De
complexes produced by the Hsp70 system, and in the
additional presence of Bag-1S, Hsp90/Hop, or both
(Figure 6B). Weak but speciﬁc signals, as indicated by
the absence of a corresponding signal in the control
lacking RT (lane 5), were obtained with Hsc70/Hsp40
alone (lane 1). Both Bag-1S (lane 2) and Hsp90/Hop
(lane 3) increased the signal intensities, and clearly the
strongest signals were obtained from the doubly supple-
mented reaction (lane 4). Although an exact quantitation
is diﬃcult, these data paralleled those in the previous
priming experiments. Hence Hsp90/Hop did not substan-
tially enhance the eﬃciency of template utilization by P
 .
While the increase in P–De complexes seen in the gel shift
assay for the Hsp90/Hop and Bag-1S supplemented
reactions would per se be compatible with an enhanced
aﬃnity of P for De RNA, this is highly unlikely in view of
the RNA titration data reported above. Hence in
combination, the two data sets strongly suggest that the
Hsp90 system increases the number, not the quality of
Hsp70 system activated RT molecules.
Figure 5. Stimulation of P activation by Bag-1S plus Hsp90/Hop.
P protein–De complexes were reconstituted from GrpDP (10nM) with
only Hsc70 and Hsp40 (ﬁlled squares), or in the additional presence of
Hsp90 and Hop (open triangles), and supplemented with the indicated
amounts of Bag-1S. Complex formation was monitored by priming
assays. Signals were quantiﬁed by phosphorimaging, normalized
to the signal obtained in the presence of Hsc70 and Hsp40 only,
and plotted against the concentration of Bag-1S. Relative priming
activities are given as means   SD from at least four independent
experiments.
Figure 6. (A) Hsp90 does not aﬀect the relative aﬃnity of P
  for De
RNA. P protein–De complexes were reconstituted with only Hsc70
and Hsp40 (open squares), or in addition with Hsp90 and Hop
(open triangles), and varying concentrations of De RNA. Complex
formation was monitored by priming assays (inset), and signal
intensities were quantiﬁed by phosphorimaging. Values were normal-
ized against the calculated maximum intensity at saturating concentra-
tion of De (I[De]/Imax; ‘fraction saturation’), and plotted against the De
RNA concentration. A hyperbolic saturation curve for a nominal
apparent Kd=0.3mM, as indicated, ﬁts equally well to both data sets.
(B) Hsp90 plus Hop, like Bag-1S, increase steady-state levels of P–De
complexes. Complex formation upon RT activation with the indicated
chaperones and co-chaperones was monitored via RNA gel shift assay.
The increases in signal strengths via stimulation by Hsp90/Hop,
Bag-1S, or a combination of both, paralleled those observed in the
corresponding priming assays.
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provean essential role for Hsp90 inhepadnavirus RT
activation inintact cells
The ansamycin antibiotic GA acts as an ADP mimic that
speciﬁcally binds into the nucleotide pocket of Hsp90 (61)
and thus blocks ATP binding and the ATP hydrolysis-
mediated Hsp90 chaperoning cycle (23). GA has been
reported to suppress DHBV replication in transfected cells
and to interfere, though at 100- to 1000-fold higher
concentrations, with priming in reticulocyte lysate by
in vitro translated RT (12,13) or recombinant RT (32).
This may suggest that Hsp90, while dispensable in the
reconstitution system, could be essential for viral DNA
synthesis under physiological conditions, although inhibi-
tion of RT activation is but one out of very many
alternative explanations for the inhibitory eﬀects of GA.
In addition, GA is now known to be a potent heat-shock
inducer, mainly via the Hsp90-controlled heat-shock
transcription factor 1 (62), and is rather cytotoxic at
higher concentrations. Two improved GA derivatives are
17-AAG and 17-DMAG (63); the latter has the added
advantage of being water-soluble. To shed more light on
the role of Hsp90 on DHBV replication in cells, we
re-examined the eﬀects of pharmacological Hsp90 inhibi-
tion on DHBV synthesis in the chicken hepatoma cell
line LMH which, though not infectable by DHBV,
supports eﬃcient DHBV replication and virus formation
when transfected with appropriate DHBV expression
vectors (3).
Preliminary dose-ﬁnding experiments (17-DMAG and
17-AAG varied from 1ng/ml to 1mg/ml) showed, after
24h of treatment with 10ng/ml or more of both drugs,
a strong increase in the relative amounts of cytoplasmic
proteins with apparent masses of around 90, 70 and
25kDa (Supplementary Figure S2); by western blotting
they were conﬁrmed to be Hsp90 and Hsc/Hsp70
(Figure 7); the 25 kDa band contained, as identiﬁed
by mass spectroscopy, Hsp27 related chicken proteins.
Incubation for 48h or longer led to a massive loss of
viable cells at the higher drug doses.
In the subsequent transfection experiments, we used
17-DMAG at concentrations of 62.5, 125, 250, 500 and
1000ng/ml. Addition of the drug immediately after the
 16h transfection period (see Materials and Methods
section for details) revealed a modest reduction
(by 30–40%) in viral DNA signal intensity at the two
highest drug doses after 48h, and a strong reduction
(by 70–80%) after 72h (Supplementary Figure S3).
However, there was a parallel loss of viable cells, manifest
by a strong reduction in the total protein content of
the lysates from which the virus DNA was isolated.
Figure 7. Eﬀects of the Hsp90 inhibitor 17-DMAG on DHBV replication in transfected LMH cells. LMH cells were incubated with the indicated
inhibitor concentrations 6h prior to and during transfection with the DHBV expression vector pCD16. Cells were kept in the presence of drug for
24h (left panels) or 48h (right panels), then cytoplasmic lysates were prepared for viral DNA and cellular protein analysis. (A) Southern blot for viral
DNA. Viral DNAs isolated from cytoplasmic nucleocapsids were detected using a
32P-labeled DHBV-speciﬁc DNA probe. RC denotes the typical
3kb relaxed circular, and dsL the double-stranded linear DNA product of reverse transcription. Lane M contained a plasmid-derived 3.0kb DHBV
marker fragment. Band intensities were quantiﬁed by phosphorimaging, and the raw data are given below each lane relative to the untreated control
set at 100% (designated absolute DNA signal). Correcting the raw data for total protein content of the corresponding lysates yielded the values
designated normalized DNA signal. (B) Impact of 17-DMAG on total protein content. Aliquots from the same lysates used for viral DNA isolation
were analyzed by SDS–PAGE analysis and Coomassie Blue staining. Only the section of the gel covering the molecular mass range between 60 and
100kDa is shown (for the full range see Supplementary Figures S2 and S3). Note the relative increase of bands at around the 90 and 70kDa position,
shown in (C) to represent Hsp90 and Hsp70. Total protein concentrations determined by the BCA assay are given below each lane relative to the
untreated sample set at 100%. (C) 17-DMAG upregulates Hsp70 and Hsp90 expression. Equal aliquots of the lysates were analyzed for Hsp90 and
Hsc70/Hsp70 by western blotting, using chemiluminescent substrates; signals were quantiﬁed using an LAS3000 imaging system. Normalized values
for Hsp90 and Hsp70 content were derived by correction for the total protein content in each lysate. Tubulin was simultaneously detected as a
loading control. The decreasing tubulin signals with increasing drug concentration parallel the decrease in total protein content.
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encapsidation is an early event in replication and because
nucleocapsids are highly stable (64), we next kept the cells
in the presence of inhibitor already 1h before and during
transfection. This time viral DNA was prepared 24 and
48h post-transfection. No speciﬁc inhibition was seen
after the short treatment period, and the reduction in
absolute DNA signal strengths at the two highest drug
concentrations after 48h ( 60 and 70%, respectively)
correlated again with a concomitant reduction in total
protein content of the lysates (Supplementary Figure S4).
Because binding of GA to Hsp90 has recently been
suggested to occur with very slow kinetics (65), we ﬁnally
started treatment of the cells 6h prior to transfection.
Under these conditions, drug dose-dependent reductions
in DNA signal intensity from  50–65% after 24h, and
50% to about 80% after 48h were observed after
correction for total protein content of the source lysates
(Figure 7A). However, not even the highest dose of
17-DMAG was able to completely block viral replication
although cell viability was already strongly aﬀected
(Figure 7B). While compatible with a similar auxiliary
but non-essential role for Hsp90 in RT activation in vivo
as in vitro, all drug concentrations tested led to a
signiﬁcant upregulation (Figure 7C) of Hsp90 (up to
2.8-fold) and Hsc70/Hsp70 (1.8- to more than 4-fold).
Hence the intricate networking between the chaperone
systems in the cell precludes clear assignments on whether
or not Hsp90 is absolutely required for DHBV replication.
We also tested the impact of 17-DMAG on the in vitro
reconstitution system, with and without Hsp90/Hop
(Supplementary Figure S5). No inhibition was detectable
at 1mg/ml (the highest dose tested in vivo); at 10mg/ml
Hsp90/Hop stimulation was substantially reduced from
 4- to 1.6-fold whereas the reaction without Hsp90/Hop
was only slightly aﬀected ( 25% reduction). At 100mg/ml,
the drug essentially abolished the priming signal in the
Hsp90/Hop supplemented reaction, similarly as previously
reported for in vitro priming in reticulocyte lysate (12,13);
however, the reaction without Hsp90/Hop was also nearly
completely inhibited. Preincubation of Hsp90 with the
drug for 1.5h to account for the potentially low on-rate of
Hsp90–inhibitor complex formation did not enhance the
inhibitory eﬀect (data not shown). Hence these data are
in line with speciﬁc inhibition of the stimulatory activity of
Hsp90at intermediate drug concentration whereas the
nearly complete inhibition at the highest dose cannot be
attributed to Hsp90-speciﬁc eﬀects.
DISCUSSION
The crucial role of chaperones for virus propagation,
though at diverse levels, is increasingly acknowledged (19).
However, obligate chaperone dependence, even in vitro,
remains a distinctive feature of the hepadnaviral P protein,
probably shared by telomerase (66–68), the cellular
RT maintaining chromosome end integrity (69). Here,
we exploited in vitro reconstitution of priming-active
DHBV RT to dissect the roles of the Hsp70 and Hsp90
systems in activation. The data ﬁrmly establish the
fundamental role of the Hsp70 system in generating a
metastable state, P
 , which is autonomously capable of De
RNA binding and authentic initiation of reverse tran-
scription. This mode of activation is diﬀerent from that
of typical Hsp90 clients such as the steroid hormone
receptors, which do not reach ligand-binding competence
without the Hsp90 system. Clearly, however, diﬀerent
from typical Hsp70 clients such as clathrin, the Hsp90
system can substantially stimulate RT activity. This
stimulation, mechanistically distinct from that exerted by
the Hsp70 nucleotide exchange factor Bag-1, requires
Hsp70-activated P
  as substrate, and it depends on Hop as
an adaptor between both chaperone systems. These data
support a model for RT activation (Figure 8) whereby
Hsp70 induces the basic conformational changes distin-
guishing P
  from P, whereas Hsp90 increases the quantity,
not the quality, of activated RT molecules. The GA
inhibition data are compatible with, but do not prove,
a similar stimulatory but non-essential role of Hsp90 for
virus replication in intact cells; importantly, they neither
provide unambiguous evidence that Hsp90 is essential.
Essential versus non-essential role ofthe Hsp90 system in
hepadnavirus RT activation
Given the evidence supporting hepadnaviral P protein
being a bona ﬁde Hsp90 client (12,13,19,33), our previous
Figure 8. Model for chaperone contributions to P protein activation.
As in the general Hsp70 chaperoning cycle, Hsp40 stimulates the
ATPase activity of Hsc70, converting Hsc70
ATP into high substrate
aﬃnity Hsc70
ADP which binds P and produces P
 -Hsc70
ADP.
Spontaneous recycling of P
 -bound Hsc70
ADP into free Hsc70
ATP is
rate limiting. Proper concentrations of Bag-1S promote ATP for ADP
exchange on Hsc70 and substrate release, enabling faster cycling and
faster production of P
 , increasing its steady-state concentration. Over-
acceleration by excess Bag-1S reduces the time span Hsc70
ADP can act
on P, reducing P to P
  conversion and thus the steady-state P
 
concentration. De RNA may react with either free P
  or P
 -Hsc70
ADP.
While the increased release of P
  by Bag-1S would favor free P
  as
binding partner, the simultaneously generated Hsc70
ATP becomes
available for a new round of P
 -Hsc70
ADP production. The cyclic
nature of this process thus prevents a clear distinction between the two
options. Hsp90 (pathway in gray) does not act directly on P but
requires prior Hsc70 action; the Hop dependence strongly suggests the
P
 –Hsc70
ADP complex, not free P
 , as Hsp90 substrate. Hsp90 increases
the steady-state levels of P
 , by slowing down decay or promoting
production, but does not induce formation of a more active form P
  
(crossed-out pathway). The exact compositions of the chaperone-
containing complexes are not known and may be subject to dynamic
changes. Similarly, not each single interaction between Hsc70 and P
may be productive in P
  generation.
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activate P protein (31) was surprising. One important
aspect of the current work is therefore that it fully
corroborates this conclusion. That Hsp90/Hop substan-
tially stimulate this basal Hsc70/Hsp40 activation
could therefore well explain why at low P protein
concentrations Hsp90/Hop were seemingly essential to
generate a detectable priming signal (33). Notably,
occasional activation of DHBV RT in the absence of
Hsp90 has been noted in the same report (33), and in vitro
binding of HBV P protein to its cognate e RNA, though
not yielding any DNA products, was at least weakly
possible with just Hsc70/Hsp40 (50). Hence activatability
without Hsp90 may be a general property of hepadnaviral
RTs.
The previously observed suppression of DHBV replica-
tion in intact cells by GA (12,13) might have suggested a
strict requirement for Hsp90 in RT activation in vivo,
questioning the physiological relevance of Hsp90 dispen-
sability in vitro. However, our thorough re-examination
of the impact of Hsp90 inhibition on virus replication
revealed severe experimental limitations of this pharma-
cological approach. First, although we used the less
toxic 17-DMAG derivative, substantial inhibition of
viral DNA synthesis required drug concentrations that
severely aﬀected cell viability. That inhibition required
several hours of pre-incubation with the drug is consistent
with a role of Hsp90at a very early replication step,
including pgRNA packaging and initiation of reverse
transcription (12,13); that a 1-h pretreatment was insuﬃ-
cient may relate to the kinetics of drug uptake and binding
to intracellular Hsp90 which is still poorly understood
(65,70). However, even the highest, barely tolerated
drug concentrations did not completely block viral DNA
synthesis. This would be expected if, as in vitro, the Hsp70
system alone were able to bring about a basal activation
of the RT. However, several issues call for a very cautious
interpretation. It is unclear whether all Hsp90 molecules in
the cell were blocked, and possibly such blockage would
be lethal. Second, the large number of cellular Hsp90
clients and genes aﬀected by GA treatment (71) leaves
many options for the inhibitory eﬀect of GA other
than preventing Hsp90-mediated RT activation. Most
importantly with regard to this study, both 17-DMAG
and 17-AAG induced a strong upregulation of Hsp70/
Hsc70, Hsp27 related proteins and Hsp90 itself; this is also
seen in various other cell types and probably mediated by
the major heat-shock transcription factor HSF-1 which is
itself regulated by Hsp90 (72). This interdependence of the
chaperone systems in the cell underscores the importance
of deﬁned in vitro systems for understanding mechanistic
aspects of client activation by chaperones.
Nucleotide exchange as rate-limiting step inHsc70/
Hsp40-mediated RTactivation in vitro
The Hsp70-speciﬁc co-chaperone Bag-1S, at optimal
concentration, stimulated Hsc70/Hsp40-driven P activa-
tion to a similar extent as Hsp90/Hop. That Bag-1S acts
genuinely on Hsc70 was demonstrated by the lack of
stimulation by a mutant Bag-1S unable to interact with
Hsc70, and by the Bag-1S-like stimulation by just the
Bag domain (construct Bag-1C) which suﬃces for
Hsc70 binding (37). Given the dependence of Hsc70-
mediated P activation on Hsp40 and on ATP hydrolysis
(31,33), this is fully in line with the general chaperoning
cycle of Hsp70 in which Bag-1 accelerates ADP for
ATP exchange (35) and thus the frequency of cycling
(Figure 7). Diﬀerent from general refolding, however,
P protein is not converted from an unfolded into a stable,
native conformation that continuously accumulates;
rather, the activated product is a metastable intermediate,
P
 , which in the absence of De RNA decays with a half-
life of minutes as soon as the chaperoning activity
of Hsc70 is interrupted by ATP depletion (31). The
resulting steady-state level of P
  will thus be determined by
the rates of generation and decay of P
 .
The clear stimulation by active Bag-1S, but not
inactive Bag-1S-R182A, demonstrates that in the non-
supplemented reaction exchange of ADP for ATP on
Hsc70 is rate limiting for P
  generation. Maximal
stimulation occurred at around 1:1 stoichiometry of
Bag-1S to Hsc70. The decline at higher Bag-1S to Hsc70
ratios is, again, in accord with the cycling model of Hsp70
chaperoning; in this case, the life span of the RT-
Hsc70
ADP complex would be so much reduced (39) that
Hsc70-mediated restructuring from P to P
  cannot occur.
Hence Bag-1S stimulation is likely based on tuning the
kinetics of the Hsp70 cycle such that the maximal number
of P
  molecules per time is generated, thus increasing their
steady-state concentration (Figure 7), as corroborated
by RNA gel shift assays (Figure 6B).
Not mutually exclusively, Hsc70 might have to be
released from P
  before De RNA can bind. Whether the
chaperone and the RNA occupy overlapping sites on the
RT is not known. Hsp70-binding sites on substrates
conform to general, rather than speciﬁc sequence motifs
(73); interestingly, one such candidate motif, predicted by
an algorithm developed for DnaK (73), overlaps with a C
terminal region in the TP domain that contains essential
residues for De RNA binding (M.S., J.B. and M.N.,
manuscript submitted), and with a region termed T3 that
appears to act as an intra- or intermolecular contact point
(74). While the functional relevance of such predictions
remains to be determined, the current data support
a model (Figure 8) whereby the Hsp70 system acts on
the RT as it does on its general substrates; the product
is, however, a speciﬁc, metastable, De RNA binding-
competent intermediate.
Predictions on the in vivo role of Bag-1 in hepadnavirus
RT activation are currently as problematic as outlined
above for Hsp90, given the plethora of isoforms (36) with
apparently opposing eﬀects (40,42,75,76), the importance
of Bag1 to Hsp70 stoichiometry [see above and ref. (39)],
and the presence of many other co-operating and
competing co-chaperones that aﬀect the Hsp70 cycle
(16). Of practical importance, the enhancement of
in vitro priming signals by Bag-1C, which is small and
easily accessible in recombinant form, should facilitate use
of the in vitro reconstitution system for screening for drugs
that aﬀect P protein activity.
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Hsp90 did not promote any RT activation in the absence
of Hsc70 or Hsp40; furthermore, in their presence,
stimulation of P activation depended on the presence
of Hop, and on the ability of Hsp90 to interact with
Hop. Clearly, therefore, Hsp70-activation must precede
Hsp90 binding. Furthermore, the established adaptor role
of Hop indicates that P
  complexed with Hsc70, not free
P
 , is the Hsp90 target (Figure 7). One way of exerting
a stimulatory eﬀect would be that Hsp90 induces
qualitative changes in P
  that promote its aﬃnity for De
RNA, or enhance its capacity to use De as template for
DNA synthesis initiation. Our data do not support such
an explanation. The same De RNA concentration
( 0.3mM) was required for half-maximal priming activity
of the Hsp70 system activated and the Hsp70 plus Hsp90
system activated RT. Second, direct monitoring of P–De
complex formation by RNA gel shift assays, though not as
accurately quantiﬁable as the priming signals, showed
comparable increases upon addition of Hsp90/Hop,
as well as Bag-1S, and a combination of the two, as
those seen in the priming assays. Combined with the RNA
titration data, this strongly suggests that the Hsp90 system
acts by increasing the steady-state concentration of
P
  generated by the Hsp70 system.
As with Bag-1S, this could be achieved by accelerating
P
  production, or by slowing down P
  decay, i.e. by
P
  stabilization. Hsp90 stimulation depended on its ability
to interact with Hop but not on ATP hydrolysis, as shown
by the substantial stimulatory activity of the variant
yHsp9016 which still binds ATP but is unable to mediate
dimerization of the N terminal Hsp90 domains (47) that
precedes ATP hydrolysis (23). Notably, this result is
highly reminiscent of the Hop-dependent stimulatory
activity of Hsp90 on Hsp70/Hsp40-mediated refolding of
luciferase (56); there another ATP-binding competent but
ATPase-deﬁcient Hsp90 variant (E46A) could also par-
tially substitute for wild-type Hsp90. Intriguingly, the
mutation did not prevent Hsp90 loading on pregesteron
receptor complexes but blocked mature complex forma-
tion and gain of ligand-binding competence. By contrast,
yHsp9016 stimulated De RNA binding by P protein
nearly as good as wild-type Hsp90 (75%). Hence diﬀerent
from steroid hormone receptors, RT activation is neither
strictly dependent on Hsp90, nor does the stimulatory
activity of Hsp90 require the full Hsp90 chaperoning
cycle. However, whether Hsp90 binding increases produc-
tion or decreases decay of P
  remains to be determined.
Mechanistic implications
Non-activated hepadnaviral RT is unable to bind its
cognate De RNA. Given that chaperones are folding
enzymes, and the ATP dependence of P activation and
stimulation, both are expected to involve transient
structural alterations in the RT that make the RNA-
binding site accessible; we therefore agree with a
previously proposed conceptual model (34), except that
we ascribe the fundamental structuring role to Hsc70
rather than Hsp90. Possibly, chaperone activity extends
to enabling the relative domain movements that must
accompany DNA synthesis. For instance, the priming Tyr
residue in the TP domain has to be properly oriented in
the polymerase active site to allow attachment of the 5’nt,
and then must move out as the primer oligo is growing,
similar to what was recently shown for the protein-
priming DNA polymerase from bacteriophage phi29 (77).
Obtaining active P–e complexes in suﬃcient amounts for
such crystallographic studies will be diﬃcult. However the
in vitro reconstitution system, combined with the data
from the current study, should help to further elucidate
how the chaperones achieve P protein activation. Limited
proteolysis of DHBV RT produced in RL has already
provided evidence for structural diﬀerences between non-
activated, and De RNA containing P protein (10,11).
The deﬁned in vitro system will now, aided by the
development of site-speciﬁc monoclonal anti-RT antibo-
dies (74), allow to sequentially follow structural altera-
tions induced by the individual chaperone systems, by the
bound De RNA, and/or by primer synthesis. Ongoing
experiments suggest, indeed, that the same basic chaper-
one components as required for RT activation also induce
signiﬁcant rearrangements in the TP domain, including
a region that is crucial for De RNA binding (M.S., J.B.,
and M.N., manuscript submitted).
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